IL18 and benign prostatic hyperplasia: Different animal models of prostatic inflammation and BHP reported a significant upregulation of NLRP3, caspase, and downstream cytokines, IL-1β and IL-18, suggesting that inflammasomes may perpetuate the inflammatory state associated with BPH [45,46,47].